Ergot (Claviceps purpurea)
What Is Ergot?
Ergot is catalogued in the Materia Medica under the binomial Claviceps purpurea, a fungus of the Clavicipitaceae family, native to the grasslands of Europe and Asia. The material in circulation is sclerotium (fungal — toxic) — a fungal fruiting body. The common name Ergot and the botanical name Claviceps purpurea refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as musty, grain-mould, faintly rancid — a practical marker of freshness and correct identification.
The written history of Ergot begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the sclerotium (fungal — toxic) contains. Beyond its practical use it carries cultural associations — implicated in the Eleusinian kykeon hypothesis and in historic mass-poisoning folklore.
Today most searches for Ergot come from people reading about infection and headache, or checking how it sits alongside a medication they already take. The use most often documented in the literature is ergotamine and dihydroergotamine remain licensed acute migraine treatments, followed by ergometrine is an essential medicine for postpartum haemorrhage.
How Does Ergot Work?
Ergot works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in sclerotium (fungal — toxic) rather than by one marker molecule.
Traditional practice described Ergot in terms of taste, warmth and preparation rather than molecules — a working vocabulary that predicted which extractions were worth making long before any compound was isolated.
The research base is comparatively solid, with controlled human trials and reviews to draw on, and this profile cites 2 sources. Reported findings centre on sclerotia contain ergotamine, ergocristine, ergometrine and related ergopeptines acting as partial agonists at serotonergic, dopaminergic and alpha-adrenergic receptors. Where research exists, it examines ergotamine and dihydroergotamine remain licensed acute migraine treatments, ergometrine is an essential medicine for postpartum haemorrhage and bromocriptine and cabergoline derive from ergoline chemistry. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into water and alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Ergot is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Ergot is documented as interacting with cyp3a4 inhibitors (macrolides, azoles, protease inhibitors), triptans and beta blockers. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Ergot can differ substantially; this is why reference entries specify sclerotium (fungal — toxic) and, where they exist, standardisation markers.